The memory care industry is one of the largest and fastest-growing segments of senior housing — and it is quietly approaching a breaking point. As the population of Americans aged 65 and over surges toward 80 million by 2040, traditional memory care facilities are struggling to differentiate, retain residents, and justify premium pricing. The model has plateaued. A new category of memory care is emerging to fill that gap. Outcome-driven programs — led by the ReCODE Protocol developed by Dr. Dale Bredesen and commercialized through Apollo Health — are demonstrating measurable improvements in cognition that traditional care simply cannot offer. For operators, families, and investors who understand what this shift means, the opportunity is significant. The Michigan Cognitive Recovery Center (MCRC) at Lakeshore Woods — opening May 1, 2026 in Fort Gratiot, Michigan — is one of only three certified ReCODE Protocol facilities in the entire United States. What that distinction means for investors is the subject of this article.
The Market Case: A $300B+ Industry Ready for Disruption
Over 55 million people worldwide are currently living with dementia. That number is projected to nearly double to 78 million by 2030, and approach 139 million by 2050. In the United States alone, Alzheimer’s affects 6.9 million Americans — a figure expected to reach 13 million by 2050. The economic footprint is immense: the Alzheimer’s Association estimates the total cost of caring for people with Alzheimer’s and other dementias in the U.S. at over $360 billion annually, with that number projected to double by mid-century. Senior memory care is not a niche — it is one of the defining healthcare challenges of the next 30 years. And yet, almost no one in this market has cracked the fundamental problem: outcomes that justify premium pricing. Traditional facilities charge high rates for what is, at its core, managed decline. Families pay — and then watch their loved ones get worse anyway. This dynamic is fueling a growing demand for something fundamentally different.
Why Traditional Memory Care Facilities Are Plateauing
Most memory care communities are built on the same model: structured environments, trained caregivers, safety protocols, and medication management. These are necessary but no longer sufficient to differentiate in a crowded, competitive market.
The structural problems with the traditional model are predictable and well-documented:
• Limited clinical differentiation — one facility’s programming looks much like another’s
• High labor costs with few levers for revenue growth
• No measurable outcomes to justify pricing — families pay for care, not results
• Occupancy plateaus as families delay placement due to perceived lack of benefit
• Referral networks that don’t actively advocate because outcomes aren’t compelling
For investors and operators who have seen this ceiling firsthand, the frustration is real. The capital required to build and operate memory care communities is substantial. The human stakes are even higher. But without an outcome-based model, growth and differentiation remain elusive.
How the ReCODE Protocol Creates a New Competitive Moat
The ReCODE Protocol changes the fundamental value proposition of memory care — from “we will care for your loved one” to “we will work to improve your loved one’s cognitive function.”
This isn’t a marketing claim. It’s a clinical methodology backed by peer-reviewed research:
• 84% of participants improved cognition under the Bredesen Protocol
• 75% experienced measurable reversal of cognitive decline symptoms
• 51% showed improved memory and cognitive function in a separate published study
• The ongoing 2025 ReCODE Clinical Trial continues to generate new evidence
These results create something traditional memory care has never had: a defensible, demonstrable outcome that justifies premium pricing and generates family loyalty.
For investors evaluating memory care assets, the ReCODE-certified model represents a meaningful competitive moat. It cannot be replicated overnight — certification requires clinical infrastructure, trained staff, Apollo Health partnership, and ongoing monitoring protocols. Early entrants gain a significant and durable market position.
Premium Positioning and the Revenue Case
Facilities that implement the ReCODE Protocol can command meaningfully higher rates — not because of luxury amenities, but because of documented clinical outcomes. Families who have seen a loved one’s cognition improve are willing to pay for continuity of that care.
The revenue upside of outcome-focused care flows through several channels:
• Premium monthly rates for specialized ReCODE programming (typically 15–30% above standard memory care)
• Longer average length of stay — families don’t move loved ones who are improving
• Higher occupancy driven by physician referrals and family word-of-mouth
• Reduced marketing cost — strong outcomes become self-sustaining referral engines
• Brand differentiation that supports expansion to new markets
The care model also delivers on the mission side of the business — a dimension that increasingly matters to ESG-aligned capital, nonprofit partners, and philanthropic investors.
Brain and Body Health Inc., the 501(c)(3) nonprofit founded by Steve Larsen, developer of MCRC at Lakeshore Woods, reflects this dual mandate: clinical excellence and mission-driven growth.
Higher Retention, Stronger NOI: The Operational Business Case
The financial mechanics of memory care are heavily influenced by length of stay and occupancy. A resident who shows cognitive improvement — or even meaningful stabilization — stays longer. A family that trusts a facility’s clinical approach does not shop alternatives. Both dynamics materially improve NOI.
Outcome-focused care changes the operational calculus in three key ways:
• Longer stays reduce the per-resident acquisition cost, improving unit economics
• Satisfied families become active referral sources, reducing marketing spend
• Clinical credibility with physicians creates a referral pipeline independent of consumer marketing
In a sector where occupancy above 90% is the goal and consistent 85%+ occupancy is a strong result, communities that can demonstrate cognitive improvement outcomes have a structural advantage — particularly as the informed, research-savvy family segment grows.
First-Mover Advantage: Why Early Adopters Like Goforth Group Are Winning
The ReCODE-certified community model is new. There are currently only three such facilities in the United States. Goforth Group, led by Steve Larsen, JD, is among the first operators in the country to build an institutional-grade ReCODE-based care model into its communities. The Michigan Cognitive Recovery Center at Lakeshore Woods opens May 1, 2026. A second community — Michigan Cognitive Recovery Center at Fenton Woods — is in development. The pipeline signals a deliberate, scalable approach to rolling out ReCODE-based programming across multiple locations. For investors, first-mover positioning in a clinically differentiated, high-demand care category is a rare combination. The barriers to replication — certification, clinical training, Apollo Health partnership, operational expertise — mean that communities implementing this model today will have a durable head start on the competition. The comparison point: when another ReCODE-certified facility opened several years ago, Apollo Health’s newsletter feature generated 100 inquiries in a single news cycle. That is the power of clinical credibility combined with a positioned launch.
The Investment Opportunity: Outcome-Focused Memory Care in 2026 and Beyond
The convergence of several forces makes this moment particularly compelling for investors paying attention to senior housing:
• An aging demographic wave that will drive decade-long demand growth for memory care
• A science-backed alternative to the traditional model that produces genuinely differentiated outcomes
• A still-small cohort of certified ReCODE operators, with significant white space ahead
• Growing family awareness and physician familiarity with the Bredesen Protocol and Apollo Health
• An active clinical trial (2025 ReCODE) that will continue generating supportive published evidence
Outcome-focused memory care is not a moonshot. It is a clinical and operational model that has been validated by research, deployed in real communities, and adopted by families who have watched their loved ones improve. The question for investors is not whether this model works — the data is there. The question is whether to be early.
Learn More & Connect
To learn more about the MCRC at Lakeshore Woods and the ReCODE Program — opening
May 1, 2026:
• ReCODE Program at Lakeshore Woods:
lakeshorewoodseniors.com/recode-program/
• Apollo Health — ReCODE Protocol:
apollohealthco.com
• Michigan Cognitive Recovery Center:
michigancognitiverecovery.com
• Goforth Group / Steve Larsen:
stevenlarsenjd.com
• 2025 ReCODE Clinical Trial:
2025rct.com